S&P 500
(-0.21%) 4 540.80 points
Dow J
(0.72%) 35 686 points
Nasdaq
(-0.82%) 14 142 points
Oil
(-1.54%) $76.66
Gas
(-0.07%) $2.80
Gold
(0.51%) $2 057.60
Silver
(2.27%) $25.64
Platinum
(-0.58%) 935.90
USD/EUR
(0.70%) 0.918
USD/NOK
(1.12%) 10.77
USD/GBP
(0.48%) 0.792
USD/RUB
(1.56%) 89.96

Realtime updates for NanoString Technologies [NSTG]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Instruments & Supplies
Last Updated30 Nov 2023 @ 13:25

-0.30% $ 0.503

Live Chart Being Loaded With Signals

Profile picture for NanoString Technologies Inc

NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific...

Stats
Today's Volume 480 842
Average Volume 2.08M
Market Cap 24.19M
EPS $0 ( 2023-11-06 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.140
ATR14 $0.0330 (6.56%)
Insider Trading
Date Person Action Amount type
2023-09-01 Beechem Joseph M Buy 564 Common Stock
2023-09-01 Gray R Bradley Buy 287 Common Stock
2023-08-28 Garland Jonathan Todd Buy 200 000 Restricted Stock Units
2023-08-28 Garland Jonathan Todd Buy 0
2023-06-23 Young William Buy 41 133 Restricted Stock Units
INSIDER POWER
68.42
Last 99 transactions
Buy: 1 646 343 | Sell: 315 847

Volume Correlation

Long: -0.39 (neutral)
Short: 0.91 (very strong)
Signal:(31) Expect same movement, but be aware

NanoString Technologies Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

NanoString Technologies Correlation - Currency/Commodity

The country flag 0.00
( neutral )
The country flag -0.32
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.60
( weak negative )

NanoString Technologies Financials

Annual 2022
Revenue: $127.26M
Gross Profit: $61.79M (48.55 %)
EPS: $-3.44
Q3 2023
Revenue: $48.09M
Gross Profit: $17.40M (36.19 %)
EPS: $-0.780
Q2 2023
Revenue: $44.16M
Gross Profit: $14.40M (32.61 %)
EPS: $-0.920
Q1 2023
Revenue: $35.81M
Gross Profit: $12.93M (36.12 %)
EPS: $-0.880

NanoString Technologies

NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.

AboutLive Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators